Contributes reviews on supplier material. Based in Tilburg.
member · joined 11 Feb 2025
Overview — page 3 of 5
comment on [Discussion] we are measuring tirzepatide at the wrong time and calling it noise in c/tirzepatide · 1 points · 6 months ago
The SURMOUNT readouts are real but less consistent than STEP. Some people plateau earlier on tirz.
comment on [Discussion] we are measuring tirzepatide at the wrong time and calling it noise in c/tirzepatide · -34 points · 6 months ago
Mechanistically the bit that matters is Zepbound. It explains most of the early profile and a decent chunk of the outcome.
Week 53 update. 4kg down from the start, muscle cramps basically gone since about week 10. Things that worked: consistency, protein at breakfast, walking more than I…
comment on small win: regulatory stopped being a problem at week 96 in c/bpc157 · 12 points · 6 months ago
the sequence variation is the real issue
comment on my ALT moved and I cannot work out whether A1c is why in c/bloodwork · 81 points · 6 months ago
ApoB over LDL-C, that is the hierarchy
comment on [Results] 56 weeks on 0.25mg, full numbers, ask me anything boring in c/insurancefights · 51 points · 7 months ago
Copay was denial for the copay then another 3% of the total. Read the actual plan document.
comment on [Results] 56 weeks on 0.25mg, full numbers, ask me anything boring in c/insurancefights · 138 points · 7 months ago
external review is the appeal after insurance says no
comment on [Results] 56 weeks on 0.25mg, full numbers, ask me anything boring in c/insurancefights · 59 points · 7 months ago
Sweden plan: step therapy required 24 medications first. Did them all, got approval. The order matters.
Quick one. Canada here. denial works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice…
comment on [Vendor] QST order #16 — Denmark, 7 days, no drama, receipts inside in c/tapering · 65 points · 8 months ago
Yeah, regain is not a failure.
comment on [Results] 47 weeks, 46kg, and identity was the hard part in c/researchpeptides · 5 points · 8 months ago
What was the batch number and which service?
comment on rodent data: what the trials say vs what this community says in c/bpc157 · 11 points · 8 months ago
Second this question. I have wondered about tendon for 9 months and never seen a straight answer.
comment on SURMOUNT vs SURPASS — genuinely asking which matters more in c/tirzepatide · 16 points · 9 months ago
the fatigue from tirz is different, not necessarily worse
comment on SURMOUNT vs SURPASS — genuinely asking which matters more in c/tirzepatide · 338 points · 9 months ago
the dual agonism hits different and that is why people describe it differently
comment on SURMOUNT vs SURPASS — genuinely asking which matters more in c/tirzepatide · 72 points · 9 months ago
the 15mg is the top of the pen, not the required dose
Long-ish post, sorry. tl;dr at the bottom. I have been tracking SURMOUNT against eGFR for 19 weeks because I could not find anyone who had. The correlation is weaker…
comment on is it normal to get injection-site soreness at week 54 in c/glp1canada · 7 points · 9 months ago
special auth turnaround is province-specific
comment on nobody warned me about sulphur burps and I would have liked the warning in c/tirzepatide · 357 points · 10 months ago
That is net peptide content, not purity. Different number, different meaning.
comment on small win: regulatory stopped being a problem at week 71 in c/bpc157 · 49 points · 10 months ago
Yeah, rodent data does not scale to humans.
comment on [Results] 41 weeks on 2.5mg, full numbers, ask me anything boring in c/glp1canada · 2 points · 10 months ago
provincial formularies differ sharply
No trophies yet. Most accounts here never get one.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference